Where does Areteia Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Areteia Therapeutics's 2 recorded funding rounds.

Premier Alternatives

Areteia Therapeutics

Drug Discovery · Chapel Hill, NC · Founded 2022 · Out of Business

Developer of an oral medication intended to treat eosinophilic asthma. Areteia Therapeutics is based in Chapel Hill, NC and was founded in 2022. Its last known valuation is $1.3 billion (Feb 2024). It has raised $425 million across 2 recorded rounds; the latest was a $425 million Series A1 in Feb 2024.

Last price · $/share

—

Implied valuation

$1.3B

Total raised

$425.0M

Last round

Early Stage VC (Series A1)

Feb 2024

Cap table — not yet on record

Areteia Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Areteia Therapeutics with a free account

·The complete investor list: 11 names
·Watch Areteia Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Areteia Therapeutics

Where does Areteia Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Areteia Therapeutics's 2 recorded funding rounds.